gambar oleh gordon johnson dari pix
The industry team consists of Battelle, Andelin Biosciences When amplified bio awarded an eight-year, $149 million contract to provide support services to a National Institutes of Health research program focused on developing treatments for neurological disorders.
The Central Ohio-based team has won multiple awards to help the National Institute of Neurological Disorders and Stroke advance the translational development of biotherapeutics under an indefinite delivery/indefinite contract will provide non-clinical and manufacturing support to the company, Battelle said Friday.
“The deal will be used to advance innovative therapies, including cell and gene therapies, for a variety of neurological diseases. ”
Jerry Hacker, executive vice president and chief commercial officer of AmplifyBio, said he looks forward to contributing the company’s preclinical research and therapeutic analytics capabilities to the pursuit of therapeutics development for neurological disorders. rice field.
Battelle brings decades of federal contract and assay and integration services experience to the team to support regulatory approvals.
